Synthetic biology promises to revolutionise a swath of industrial activities and create new ones by tailoring living systems to produce a range of products to boost economies, transform health and contribute to solving grand societal challenges.
Markus Schmidt, expert from deCYPher partner Biofaction, contributed to the OECD (Organisation for Economic Co-operation and Development) Science, Technology and Industry Working Paper, titled Synthetic Biology in Focus: Policy Issues and Opportunities in Engineering Life.
In 2023 and 2024, OECD convened 66 experts from research, government, academia, non-governmental and industry backgrounds from 32 countries to share insights and provided evidence on the technical, social and policy issues facing synthetic biology. Its aim is to inform policymakers of the key areas where experts believe action could be taken to foster a strong bioeconomy, provide wide-ranging societal benefits, and mitigate potential risks.
This working paper provides a synthesis of this scoping activity, offering an accessible text for those new to the rapidly evolving area of synthetic biology.
You can read the full paper here: oecd.org/content/dam/oecd/en/publications/reports/2025/02/synthetic-biology-in-focus_42893a6a/3e6510cf-en.pdf
Recent Comments